Resultados de búsqueda - Hughes, Eric A

Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome por Hughes, Eric A., Hammond, Craig, Cresswell, Peter

Enlace del recurso Enlace del recurso

Case Report of Successful Peginterferon, Ribavirin, and Daclatasvir Therapy for Recurrent Cholestatic Hepatitis C After Liver Retransplantation por Fontana, Robert J., Hughes, Eric A., Appelman, Henry, Hindes, Robert, Dimitrova, Dessislava, Bifano, Marc

Enlace del recurso Enlace del recurso Enlace del recurso

Induction of transporter associated with antigen processing by interferon γ confers endothelial cell cytoprotection against natural killer-mediated lysis por Ayalon, Oran, Hughes, Eric A., Cresswell, Peter, Lee, Jennifer, O’Donnell, Lynn, Pardi, Ruggero, Bender, Jeffrey R.

Enlace del recurso Enlace del recurso

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics por LaVange, Lisa, Adam, Stacey J., Currier, Judith S., Higgs, Elizabeth S., Reineck, Lora A., Hughes, Eric A., Read, Sarah W.

Enlace del recurso Enlace del recurso Enlace del recurso

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence por Poordad, Fred, Schiff, Eugene R., Vierling, John M., Landis, Charles, Fontana, Robert J., Yang, Rong, McPhee, Fiona, Hughes, Eric A., Noviello, Stephanie, Swenson, Eugene S.

Enlace del recurso Enlace del recurso Enlace del recurso

Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials por Buchman, Timothy G., Draghia-Akli, Ruxandra, Adam, Stacey J., Aggarwal, Neil R., Fessel, Joshua P., Higgs, Elizabeth S., Menetski, Joseph P., Read, Sarah W., Hughes, Eric A.

Enlace del recurso Enlace del recurso Enlace del recurso

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1 por Jacobson, Ira, Zeuzem, Stefan, Flisiak, Robert, Knysz, Brygida, Lueth, Stefan, Zarebska-Michaluk, Dorota, Janczewska, Ewa, Ferenci, Peter, Diago, Moises, Zignego, Anna Linda, Safadi, Rifaat, Baruch, Yaacov, Abdurakhmanov, Dzhamal, Shafran, Stephen, Thabut, Dominique, Bruck, Rafael, Gadano, Adrian, Thompson, Alexander James, Kopit, Justin, McPhee, Fiona, Michener, Tracy, Hughes, Eric A, Yin, Philip D, Noviello, Stephanie

Enlace del recurso Enlace del recurso Enlace del recurso

All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study por Nelson, David R, Cooper, James N, Lalezari, Jacob P, Lawitz, Eric, Pockros, Paul J, Gitlin, Norman, Freilich, Bradley F, Younes, Ziad H, Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J, Ortiz-Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M, Varunok, Peter, Kowdley, Kris V, Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A

Enlace del recurso Enlace del recurso Enlace del recurso